MENU
+Compare
STAA
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$26.02
Change
+$0.17 (+0.66%)
Capitalization
1.28B

STAA STAAR Surgical Company Forecast, Technical & Fundamental Analysis

Staar Surgical Co is a manufacturer of lenses... Show more

STAA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STAA with price predictions
Nov 12, 2025

STAA in downward trend: 10-day moving average crossed below 50-day moving average on October 10, 2025

The 10-day moving average for STAA crossed bearishly below the 50-day moving average on October 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on November 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on STAA as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

STAA moved below its 50-day moving average on November 12, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STAA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for STAA entered a downward trend on October 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where STAA's RSI Indicator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for STAA just turned positive on November 07, 2025. Looking at past instances where STAA's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STAA advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

STAA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STAA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.631) is normal, around the industry mean (10.242). P/E Ratio (49.727) is within average values for comparable stocks, (158.743). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.733). STAA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (5.580) is also within normal values, averaging (111.072).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STAA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
STAA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STAA is expected to report earnings to fall 46.22% to 9 cents per share on February 25

STAAR Surgical Company STAA Stock Earnings Reports
Q4'25
Est.
$0.10
Q3'25
Est.
$0.18
Q2'25
Beat
by $0.22
Q1'25
Missed
by $0.52
Q4'24
Missed
by $0.66
The last earnings report on November 05 showed earnings per share of 18 cents, meeting the estimate of 18 cents. With 392.62K shares outstanding, the current market capitalization sits at 1.28B.
A.I. Advisor
published General Information

General Information

a designer of implantable lenses for the eye and delivery systems used to deliver lenses into the eye

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
25651 Atlantic Ocean Drive
Phone
+1 626 303-7902
Employees
1115
Web
https://www.staar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWALX37.900.26
+0.69%
Nationwide BNY Mellon Dyn US Eq Inc A
FLCCX49.66N/A
N/A
Fidelity Advisor Large Cap C
PSVIX15.39-0.02
-0.13%
Virtus NFJ Small-Cap Value Inst
JEMSX41.84-0.11
-0.26%
JPMorgan Emerging Markets Equity I
TGRYX12.39-0.06
-0.48%
TCW Global Real Estate N

STAA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with XRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-5.66%
XRAY - STAA
53%
Loosely correlated
-1.28%
WST - STAA
44%
Loosely correlated
-1.28%
OFIX - STAA
38%
Loosely correlated
-0.52%
CSTL - STAA
38%
Loosely correlated
-0.43%
IQV - STAA
37%
Loosely correlated
+1.08%
More

Groups containing STAA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-5.66%
Pharmaceuticals
category (378 stocks)
24%
Poorly correlated
-0.99%
Pharmaceuticals: Other
category (103 stocks)
18%
Poorly correlated
-1.40%